Position in GOSS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,067
-$59,530 QoQ
Shares Held
212,531
-26.1% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 168 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Derivatives in GOSS
reported options exposure · as of Dec 31, 2025CallValue
$108,810
CallShares
35,100
PutValue
$1,435,920
PutShares
463,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,452,202 across 192 Biotechnology names. GOSS ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in GOSS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,067 | 212,531 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $94,597 | 287,531 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $658,846 | 212,531 | Shares | Sole | 2026-02-18 | |
| 2025-12-31 | $108,810 | 35,100 | Call | Sole | 2026-02-18 | |
| 2025-12-31 | $1,435,920 | 463,200 | Put | Sole | 2026-02-18 | |
| 2025-09-30 | $144,913 | 55,100 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $558,956 | 212,531 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $279,490 | 227,228 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $249,950 | 227,228 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,007 | 19,898 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $267,529 | 295,613 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $411,120 | 416,958 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $19,720 | 20,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $18,020 | 20,000 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $479,897 | 532,628 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $864,501 | 732,628 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $650,994 | 713,028 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||